Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer

Currently, tamoxifen is the only drug approved for reduction of breast cancer risk in premenopausal women. The significant cardiovascular side effects of tamoxifen, coupled with lack of a survival benefit, potential for genotoxicity, and failure to provide a significant risk-reduction for estrogen r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Public Health
Main Authors: Jones, Veronica C., Dietze, Eric C., Jovanovic-Talisman, Tijana, McCune, Jeannine S., Seewaldt, Victoria L.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Public Health
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7658387/
https://ncbi.nlm.nih.gov/pubmed/33194937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpubh.2020.509714
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados